Professor Christos Pantelis is an Australian professor of medicine who is the Director of the Melbourne Neuropsychiatry Centre.
Prof. Christos Pantelis is an Australian of Greek background. [1] He completed his medical degree at the University of Melbourne and trained at St Vincent's Hospital in Melbourne. Two years later, in 1979, he commenced his training in psychiatry at the Royal Free Hospital in London, England. During his training, he spent 18 months as a Research Registrar at University College Hospital to undertake an epidemiological study of schizophrenia in Inner London. He was appointed as a lecturer at Charing Cross & Westminster Medical School (UK) in 1988. In this position, he worked in the Academic Unit at Horton and the Gordon Hospitals, headed by Professor Thomas R.E. Barnes. The unit was involved in a number of research studies in schizophrenia including phenomenology, psychopharmacology, studies on movement disorder, neuropsychological aspects of schizophrenia, as well as epidemiology and social psychiatric aspects of schizophrenia.
In 1992, he was awarded the Lilly Travelling Fellowship of the Royal College of Psychiatrists and the King Edward's Hospital Fund for London, England. During this year, he was Travelling Research Fellow with the National Institute of Mental Health (Washington, DC), where he worked with Dr. Richard Coppola and Dr. Daniel Weinberger, developing a technique for volumetric analysis of brain MRI images. He then returned briefly to the UK as a Research Fellow.
After his return from England at the end of 1992, Prof. Christos Pantelis worked at the Mental Health Research Institute and at Royal Park Psychiatric Hospital. He established the Cognitive Neuropsychiatry Research Unit, which is now based at both the Mental Health Research Institute and Sunshine Hospital. He also heads the Academic Unit at Sunshine Hospital. He became a Fellow of the Royal Australian and New Zealand College of Psychiatrists in 1999.
Prof. Pantelis was Director of the inpatient rehabilitation program at Royal Park Hospital until mid-1996. During this time, he was responsible for the inpatient rehabilitation program and was instrumental in developing a comprehensive Model of Care for patients with long-term mental illness, and establishing a region-wide coordinating committee to oversee developments in delivery of services to these patients. He is currently Clinical Director and Principal Specialist for the Adult Mental Health Rehabilitation Unit (AMHRU) at Sunshine Hospital. This is a 26-beds unit for patients with treatment-resistant psychoses. He was actively involved in planning the movement of the Rehabilitation Unit to Sunshine Hospital and in the establishment of an Academic and Research Unit at that site. This included providing expertise into the architectural design of the new clinical and research units. These units opened in early 2000.
This section of a biography of a living person does not include any references or sources .(November 2022) |
Prof. Christos Pantelis has established an internationally recognised group in the field of schizophrenia research, particularly in the neuropsychology and neuroimaging of the disorder. He has published numerous papers in peer reviewed journals, including papers in the Archives of General Psychiatry, as well as recent papers in Brain, Brain Research Reviews, Psychological Medicine, and other international journals. He has published a book on schizophrenia from a neuropsychological perspective.
He is highly experienced in the application of both structural and functional brain imaging to psychiatric disorders and has been awarded a number of NH & MRC grants, as well as a major imaging grant from the Ian Potter Foundation. He is also a member of the NH & MRC Brain Network. This work has been internationally recognised with invited talks to the UK and Europe. He is part of an international group looking at the neurobiology of schizophrenia. This work was presented at a number of invited symposia in Europe and USA.
His most recent work challenges the current neurodevelopmental hypothesis of schizophrenia in showing progressive changes in this disorder. In particular they have demonstrated that brain structural abnormalities are occurring during the transition phase to psychosis in individuals at high risk for developing schizophrenia.
Cognitive neuropsychiatry is a growing multidisciplinary field arising out of cognitive psychology and neuropsychiatry that aims to understand mental illness and psychopathology in terms of models of normal psychological function. A concern with the neural substrates of impaired cognitive mechanisms links cognitive neuropsychiatry to the basic neuroscience. Alternatively, CNP provides a way of uncovering normal psychological processes by studying the effects of their change or impairment.
Anthony David FMedSci is a British neuropsychiatrist based at University College London. Previously tenured as professor of cognitive neuropsychiatry and Vice Dean at the Institute of Psychiatry, King's College London, since 2018 he has been Director, University College London, Institute of Mental Health. He is the father of Rebecca David, a Senior Campaign Manager at Influencer LTD and Michael David a junior doctor.
The Institute of Psychiatry, Psychology and Neuroscience (IoPPN) is a research institution dedicated to discovering what causes mental illness and diseases of the brain. In addition, its aim is to help identify new treatments for them and ways to prevent them in the first place. The IoPPN is a faculty of King's College London, England, previously known as the Institute of Psychiatry (IoP).
Social psychiatry is a branch of psychiatry that focuses on the interpersonal and cultural context of mental disorder and mental wellbeing. It involves a sometimes disparate set of theories and approaches, with work stretching from epidemiological survey research on the one hand, to an indistinct boundary with individual or group psychotherapy on the other. Social psychiatry combines a medical training and perspective with fields such as social anthropology, social psychology, cultural psychiatry, sociology and other disciplines relating to mental distress and disorder. Social psychiatry has been particularly associated with the development of therapeutic communities, and to highlighting the effect of socioeconomic factors on mental illness. Social psychiatry can be contrasted with biopsychiatry, with the latter focused on genetics, brain neurochemistry and medication. Social psychiatry was the dominant form of psychiatry for periods of the 20th century but is currently less visible than biopsychiatry.
The Florey Institute of Neuroscience and Mental Health, more commonly known as the Florey Institute, is an Australian medical research institute that undertakes clinical and applied research into treatments for brain and mind disorders and the cardiovascular system. The institute's areas of interest include Parkinson's disease, stroke, motor neurone disease, traumatic brain and spinal cord injury, addiction, epilepsy, multiple sclerosis, brain development in premature babies, Autism, Huntington's disease, depression, schizophrenia, brain function in health and disease, heart failure, and dementia.
The Melbourne Neuropsychiatry Centre (MNC), is a joint centre of University of Melbourne and Melbourne Health in Australia. It brings together clinical and research teams at Sunshine and Royal Melbourne Hospitals, with a dedicated brain imaging archive and analysis laboratory located at the University's Parkville campus.
Neuropsychiatry or Organic Psychiatry is a branch of medicine that deals with psychiatry as it relates to neurology, in an effort to understand and attribute behavior to the interaction of neurobiology and social psychology factors. Within neuropsychiatry, the mind is considered "as an emergent property of the brain", whereas other behavioral and neurological specialties might consider the two as separate entities. Neuropsychiatry preceded the current disciplines of psychiatry and neurology, which previously had common training, however, those disciplines have subsequently diverged and are typically practiced separately.
The Institute of Living is a comprehensive psychiatric facility in Hartford, Connecticut, that offers care across the spectrum of psychiatric services, including:
Gartnavel Royal Hospital is a mental health facility based in the west end of Glasgow, Scotland. It provides inpatient psychiatric care for the population of the West of the City. It used to house the regional adolescent psychiatric unit but this has recently moved to a new psychiatric unit at Stobhill Hospital. The Hospital is a venue used by the Mental Health Tribunal for Scotland. Some parts of the hospital are classified as a category A building and are also deemed at risk.
Region Hovedstadens Psykiatri is a psychiatric hospital with centers spread all around the capital region of Denmark, mainly consisting of Copenhagen, northern Zealand, and Bornholm.
Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of mental conditions. These include various issues related to mood, behaviour, cognition, and perceptions.
Alice Medalia is an American clinical neuropsychologist and international leader in the field of psychiatric rehabilitation. She is best known for her work treating cognitive deficits in people with psychiatric disorders. This subspecialty is known as cognitive remediation.
The Royal Australian and New Zealand College of Psychiatrists (RANZCP) is the principal organisation representing the medical specialty of psychiatry in Australia and New Zealand and has responsibility for training, examining and awarding the qualification of Fellowship of the College (FRANZCP) to medical practitioners.
The National Psychosis Unit is a national treatment centre for patients with schizophrenia and other psychotic disorders, in the United Kingdom. The unit is a tertiary referral centre in the National Health Service. It is located at the Bethlem Royal Hospital, part of the South London and Maudsley NHS Foundation Trust. It is closely affiliated to the Institute of Psychiatry, King's College London, and forms part of the Psychosis Clinical Academic Group of King's Health Partners.
Perminder Sachdev is an Indian neuropsychiatrist based in Australia. He is a professor of neuropsychiatry at the University of New South Wales (UNSW), co-director of the UNSW Centre for Healthy Brain Aging, and clinical director of the Neuropsychiatric Institute at the Prince of Wales Hospital, Sydney. He is considered a trailblazer in the field of neuropsychiatry. Sachdev's research interests include ageing, vascular cognitive disorders such as vascular dementia, and psychiatric disorders.
Bakırköy Psychiatric Hospital, short for Bakırköy Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital, is a mental health hospital of the Health Ministry located in Bakırköy district of Istanbul, Turkey. The hospital is named after Mazhar Osman, who is also considered the founder of modern psychiatry in Turkey.
Sir Michael John Owen is a Welsh research scientist in the area of psychiatry, currently the head of the Division of Psychological Medicine and Clinical Neurosciences at Cardiff University.
Professor Susan Rossell is a British researcher based at Swinburne University of Technology specialising in Neuropsychology and Neuroimaging. Originally from Nottingham, UK; she now resides in Melbourne, Australia. Her research on the neuropsychology of schizophrenia and body dysmorphic disorder is internationally recognised.
Elizabeth Scarr is an Australian scientist. Her research investigates the chemical changes in the brain associated schizophrenia and bipolar disorder.
F. Markus Leweke is a German psychiatrist and psychotherapist. He is a professor and Chair in Youth Depression Studies at the Brain and Mind Centre of the University of Sydney, Australia and a work group leader at the Central Institute of Mental Health in Mannheim, Germany.